Fundz

Acrivon Appoints Michaela Levin as Chief Business Officer

PUBLIC · ACRVAug 31, 2026

Position

Chief Business Officer

Company

Acrivon Therapeutics

Michaela Levin
WatertownBiotechnologyHealth CareMedicalTherapeuticsBiopharma

Description

Acrivon Therapeutics, Inc. announced the appointment of Michaela Levin, Ph.D., as Chief Business Officer, effective August 31, 2026. Dr

Who to call at Acrivon Therapeutics, and when

A new leader at Acrivon Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Acrivon Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acrivon Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acrivon Therapeutics

Location

480 Arsenal Way Suite 100

Watertown, Massachusetts, United States

About

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acrivon Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Adam
Likely contact at this company
••••••••@••••••••

See Adam's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Acrivon Therapeutics's next move

Learn about Strategic plan

Acrivon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.